腹腔置管注药并引流治疗干酪型结核性腹膜炎的疗效观察  

Clinical study on therapeutic effect of drainage and drug administration by abdominal dwell catheter in treatment of caseous tuberculous peritonitis

作　　者：邓国防[1] 孙丽珍[1] 雷建平[1] 

机构地区：[1]江西省胸科医院消化科,南昌330006

出　　处：《临床内科杂志》2010年第8期528-530,共3页Journal of Clinical Internal Medicine

基　　金：本课题受江西省卫生厅科技计划基金资助项目（20081141）

摘　　要：目的 探讨腹腔置管注药并引流治疗干酪型结核性腹膜炎的临床疗效.方法 选择符合诊断条件的干酪型结核性腹膜炎患者60例,分为两组,对照组应用抗结核药物全身化疗;实验组应用腹腔置管注药并引流＋全身化疗.观察两组患者发热、腹痛、腹胀、呕吐、便秘等症状缓解时间;腹腔分房及包裹性积液消退程度;腹部包块及腹腔淋巴结肿大消退程度.结果 治疗4周时,病人症状缓解时间、腹腔分房及包裹性积液消退程度和腹部包块及腹腔淋巴结肿大消退程度,两组比较差异有统计学意义（P＜0.01）.结论 腹腔置管注药并引流治疗技术可减轻腹腔粘连包裹,缓解患者症状,减少肠梗阻及结核性化脓性腹膜炎的发生机会,提高好转率及治愈率.且安全简便、无明显并发症,值得临床推广应用.Objective To evaluate the therapeutic effect of drainage and drug administration by abdominal dwell catheter in treatment of caseous tuberculous peritonitis. Methods 60 accorded with the diagnosis of caseous tuberculous peritonitis were randomly divided into the therapeutic group and the control group. The patients in therapeutic group were treated with anti-tuberculosis chemotherapy via venous accompanied with drainage and anti-tuberculosis drug administration by abdominal dwell catheter. The patients in control group were treated with anti-tuberculosis chemotherapy alone. The clinical causes of the fever,abdominal pain,abdominal distension,vomiting,constipation were observed after therapy. Results In 4 weeks after treatment, the symptom persitance time, encapsulated effusion, abdominal separation and celiac lymphadenectasis were significantly decreased in therapeutic group than in control group （P 〈 0. 01 ）. Conclusion Treatment of drainage and drug administration by abdominal dwell catheter is a safe and effective way to therapy caseous tuberculous peritonitis. This methods can reduce the symptom persitance time, encapsulated effusion, abdominal separation and celiac lymphadenectasis.

关 键 词：结核性腹膜炎 干酪型 腹腔内注药 

分 类 号：R572.2[医药卫生—消化系统]